AzTrials
AzTrials

StrokeNESTNCT07572487

User Requirements of the Neurorehabilitation Ecosystem for Sustained Therapy

An observational study of Stroke, run by Sint Maartenskliniek at 3 sites in 3 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study the user requirements of the Neurorehabilitation Ecosystem for Sustained Treatment (NEST), a system containing: an exercise app, smartwatch and virtual coach designed for stroke survivors, will be investigated. Focus groups or interviews will be held in three countries, Italy, Spain and the Netherlands. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stroke
How many people
40 participants
Where
3 sitesin 3 countries
Study dates
15 Jan 2022to 15 Aug 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All healthcare professionals worked at the participating centres. All stroke survivors received or were still receiving treatment at the participating centres. Most caregivers were related to the participating stroke survivors or recruited via social media.

Who may be able to join

  • People who had a stroke and were discharged from the rehabilitation center within one year from now.
  • Range of different hand functioning measured with the Fugl-Meyer Assessment (only the upper extremity part will be used)
  • 18 years or older
  • An informal caregiver of a stroke patient (mostly a family member or friend)
  • Stroke patient was discharged within one year from now
  • 18 years or older
  • Working as a therapist in one of the centres
  • Working with stroke patients on a daily basis

Who cannot join

  • Low cognitive functioning, with a mini mental state examination score below 21
  • Extremely limited smartphone user
  • Patients suffering from aphasia
  • Caregivers:
  • Extremely limited smartphone user
  • Healthcare professionals:
  • Extremely limited smartphone user

Trial locations and contacts

3 sites in 3 countries.

3 sites in 3 countries

Italy1 site
  • INRCA

    Ancona

Other trials in Italy

Netherlands1 site
  • Sint Maartenskliniek

    Ubbergen

Other trials in Netherlands

Spain1 site
  • Vall d'Hebron

    Barcelona

Other trials in Spain

About this study

Official title: User Requirements of the Neurorehabilitation Ecosystem for Sustained Therapy (NEST): an Integrated Home-based Rehabilitation Tool

In this study the user requirements of the Neurorehabilitation Ecosystem for Sustained Treatment (NEST), a system containing: an exercise app, smartwatch and virtual coach designed for stroke survivors, will be investigated. Focus groups or interviews will be held in three countries, Italy, Spain and the Netherlands. During these focus groups open-ended questions will be asked about the different components of NEST.

Read the detailed description

After stroke, patients often experience a reduced arm-function. This function can partly be regained during a long and intensive rehabilitation. However, due to the ageing population and the increasing stroke cases, there is not enough time and money for this long and intensive rehabilitation in a rehabilitation center. Home-based rehabilitation could offer a solution to this problem. Currently, a new home-based rehabilitation system is being developed, named the Neurorehabilitation Ecosystem for Sustained Treatment (NEST). This system consists of three different components: an app, in which games can be played; a smartwatch which monitor the arm function of the patient and a virtual coach which will motivate the patient. However, this system is still being developed and it is unknown whether it meets the user requirements.

Therefore, the goal of this study is to identify factors for NEST to maximize usability, acceptance and usefulness by stroke patients, therapists and caregivers in the home situation. We conducted a qualitative focus group study, with 5 patients, 5 caregivers and 5 therapists in each of the three centers in Italy, Spain and the Netherlands. In each of the three centers, 3 focus groups or interviews will take place; one with patients, one with caregivers and one with therapists. First an introduction will be given in which the participants will see a video of NEST. Then questions about the systems will be asked. In total this will take 2 hours with a 30-minute break for patients. The main objective of this study is to get a list with factors that NEST needs to fulfill in order for it to be used by patients, caregivers and therapists. This will come out of an inductive thematic analysis from the focus groups.

Conditions
Stroke
Keywords
focus group, interview, user requirements, home-based rehabilitation, stroke
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07572487
Study groupRoleWhat they receive
Stroke survivorsStroke survivors with an affected upper limb function due to stroke
CaregiversCaregivers who support a stroke survivor in their close environment
Healthcare professionalsHealthcare professionals with experience in working with stroke survivors on a daily basis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Inductive thematic analysis on user requirements gained during focus groups

    Focus groups will be held. One with stroke survivors, one with caregivers and one with healthcare professionals. The researcher will be the leader.

    Measured: 2 hours

  2. Inductive thematic analysis on user requirements gained during interviews

    Interviews between the researcher and either stroke survivors, caregivers or healthcare professionals.

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2026
  2. Study start15 Jan 2022
  3. Primary completion15 Aug 2022
  4. Study completion15 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07572487
Sponsor's protocol ID
1027
Acronym
NEST
Status last verified
Oct 2024
First submitted
18 Oct 2024
Last updated
7 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Due to the nature of the data (interviews and focus groups) it is not possible to provide complete anonymized data.

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by Sint Maartenskliniek at 3 sites in 3 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Italy, Netherlands, Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Inductive thematic analysis on user requirements gained during focus groups (time frame: 2 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in